Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Anti-CD151 antibodies and their use in the treatment of cancer

Anti-CD151 antibodies and their use in the treatment of cancer

US Patent 8198413 · Granted Jun 12, 2012

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Sulfomaleimide-based linkers and corresponding conjugates2024
Immunocytokines for the treatment of cancer2023
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2023
Antibody-drug-conjugate and its use for the treatment of cancer2022
Composition for the treatment of IGF-1R expressing cancer2020
IGF-1R antibody-drug-conjugate and its use for the treatment of cancer2020
Antibody-drug-conjugate and its use for the treatment of cancer2019
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses there2014
Anti-CD151 antibodies and their use in the treatment of cancer2014
Use of an anti-CD151 antibody in the treatment of cancer2012
Anti-IGF-IR antibodies and uses thereof2012
Anti-IGF-IR and/or anti-insulin/IGF-I hybrid receptors antibodies and uses there2012